6 assets in Neoplasm Of Mature B-Cells

Therapeutic assets addressing Neoplasm Of Mature B-Cells, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Copad Neoplasm Of Mature B-Cells	St. Jude Children's Research Hospital	P2/3	B (57)
Zanubrutinib Neoplasm Of Mature B-Cells	BeOne Medicines	P1/2	B (57)
Obinutuzumab Neoplasm Of Mature B-Cells	BeOne Medicines	P1	CC (43)
Sonrotoclax Neoplasm Of Mature B-Cells	BeOne Medicines	P1	CC (43)
Sgr-1505 Neoplasm Of Mature B-Cells	Schrödinger, Inc.	P1	NR ()